Eugene Myron Holuka - Oct 10, 2023 Form 4 Insider Report for Citius Pharmaceuticals, Inc. (CTXR)

Role
Director
Signature
/s/ Alexander M. Donaldson, by power of attorney
Stock symbol
CTXR
Transactions as of
Oct 10, 2023
Transactions value $
$0
Form type
4
Date filed
10/12/2023, 04:15 PM
Previous filing
Oct 6, 2022
Next filing
Aug 30, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CTXR Options to Purchase Common Stock Award $0 +75K $0.00 75K Oct 10, 2023 Common Stock 75K $0.70 Direct F1
holding CTXR Options to Purchase Common Stock 75K Oct 10, 2023 Common Stock 75K $1.25 Direct F2
holding CTXR Options to Purchase Common Stock 75K Oct 10, 2023 Common Stock 75K $2.04 Direct F3
holding CTXR Options to Purchase Common Stock 15K Oct 10, 2023 Common Stock 15K $2.00 Direct F4
holding CTXR Options to Purchase Common Stock 25K Oct 10, 2023 Common Stock 25K $1.69 Direct F5
holding CTXR Options to Purchase Common Stock 35K Oct 10, 2023 Common Stock 35K $1.01 Direct F6
holding CTXR Options to Purchase Common Stock 25K Oct 10, 2023 Common Stock 25K $1.39 Direct F7
holding CTXR Options to Purchase Common Stock 25K Oct 10, 2023 Common Stock 25K $0.67 Direct F8
holding CTXR Options to Purchase Common Stock 15K Oct 10, 2023 Common Stock 15K $1.62 Direct F9
holding CTXR Options to Purchase Common Stock 10K Oct 10, 2023 Common Stock 10K $3.45 Direct F10
holding CTXR Options to Purchase Common Stock 2.42K Oct 10, 2023 Common Stock 2.42K $0.02 Direct F11
holding CTXR Options to Purchase Common Stock 13.3K Oct 10, 2023 Common Stock 13.3K $12.00 Direct F12
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options were granted on October 10, 2023. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date.
F2 The options vested in full on October 4, 2023.
F3 The options vested in full on October 11, 2022.
F4 The options vested in full on July 22, 2022.
F5 The options vested in full on February 16, 2022.
F6 The options vested in full on October 6, 2021.
F7 The options vested in full on July 7, 2021.
F8 The options vested in full on October 8, 2020.
F9 The options vested in full on September 4, 2019.
F10 The options vested in full on September 13, 2018.
F11 The options vested in full on April 14, 2016.
F12 The options vested in full on June 23, 2017.